3 results
P
patients with colorectal cancer (CRC) and synchronous liver metastases (SCRLM)
I/C
bowel-first approach (BFA), simultaneous resection (SIM), liver-first approach (LFA), BFA vs. LFA, SIM vs. LFA
O
postoperative complications, 30- and 90-day mortality, chemotherapy use, treatment completion rate, 3- and 5-year recurrence-free survival, 3- and 5-year overall survival (OS)
P
animal models
I/C
calcium phosphate carried simvastatin, cloth or calcium phosphate alone
O
bone formation and regeneration
P
51956 participants
I/C
7 different statins (simvastatin, fluvastatin, atorvastatin, rosuvastatin, lovastatin, pravastatin, and pitavastatin), comparing the lipid-lowering efficacy of no less than two of the included statins (or statin vs. placebo)
O
LDL-C lowering
